{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T20:11:35Z","timestamp":1781813495449,"version":"3.54.5"},"reference-count":51,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2007,12,10]],"date-time":"2007-12-10T00:00:00Z","timestamp":1197244800000},"content-version":"vor","delay-in-days":2779,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Echocardiography"],"published-print":{"date-parts":[[2000,5]]},"abstract":"<jats:p>Atrial fibrillation is a major clinical problem that is predicted to be encountered more frequently as the population ages. The clinical management of atrial fibrillation has become increasingly complex as new therapies and strategies have become available for ventricular rate control, conversion to sinus rhythm, maintenance of sinus rhythm, and prevention of thromboembolism. Clinical and transthoracic echocardiographic features are important in determining etiology and directing therapy for atrial fibrillation. Left atrial size, left ventricular wall thickness, and left ventricular function have independent predictive value for determining the risk of developing atrial fibrillation. Left atrial size may have predictive value in determining the success of cardioversion and maintaining sinus rhythm in selected clinical settings but has less value in the most frequently encountered group, patients with nonvalvular atrial fibrillation, in whom the duration of atrial fibrillation is the most important feature. When selecting pharmacological agents to control ventricular rate, convert to sinus rhythm, and maintain normal sinus rhythm, transthoracic echocardiography (TTE) allows noninvasive evaluation of left ventricular function and hence guides management. The combination of clinical and transthoracic echocardiographic features also allows risk stratification for thromboembolism and hemorrhagic complications in atrial fibrillation. High\u2010risk clinical features for thromboembolism supported by epidemiological observations, results of randomized clinical trials, and meta\u2010analyses include rheumatic valvular heart disease, prior thromboembolism, congestive heart failure, hypertension, older (&gt; 75 years old) women, and diabetes. Small series of cases also suggest those with hyperthyroidism and hypertrophic cardiomyopathy are at high risk. TTE plays a unique role in confirming or discovering high\u2010risk features such as rheumatic valvular disease, hypertrophic cardiomyopathy, and decreased left ventricular function. Validation of the risk stratification scheme used in the Stroke Prevention in Atrial Fibrillation\u2010III trial is welcomed by clinicians who are faced daily with balancing the benefit and risks of anticoagulation to prevent thromboembolism inpatients with atrial fibrillation.<\/jats:p>","DOI":"10.1111\/j.1540-8175.2000.tb01151.x","type":"journal-article","created":{"date-parts":[[2007,12,10]],"date-time":"2007-12-10T15:14:34Z","timestamp":1197299674000},"page":"357-364","source":"Crossref","is-referenced-by-count":17,"title":["Role of Transthoracic Echocardiography in Atrial Fibrillation"],"prefix":"10.1111","volume":"17","author":[{"given":"RICHARD W.","family":"ASINGER","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,12,10]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(96)90288-4"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198204293061703"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)80348-9"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1995.00430050045005"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1989.00520430021013"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.1998.1050"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198709103171104"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8651(05)70303-9"},{"key":"e_1_2_1_10_2","first-page":"269","article-title":"Role of echocardiography in primary care medicine: Controversies in hypertension, atrial fibrillation, stroke, and endocarditis","volume":"164","author":"Amidon TM","year":"1996","journal-title":"West J Med"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.95.3.572"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.62.2.395"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03510350050036"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.89.2.724"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(87)90253-0"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.82.3.792"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/clc.4960140806"},{"key":"e_1_2_1_18_2","article-title":"Atrial fibrillation begets atrial fibrillation: A study in awake chronically instrumented goats","volume":"92","author":"Wijfells MCEF","year":"1995","journal-title":"Circulation"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.51.2.273"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(89)90602-5"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(93)90593-P"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(91)90108-W"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(94)90652-1"},{"key":"e_1_2_1_24_2","first-page":"91","article-title":"Improvement of the cardiac function after electrical cardioversion of atrial fibrillation: Echocardiographic study in patients with and without mitral stenosis","volume":"12","author":"Leri Z","year":"1982","journal-title":"Giornale Ital Cardiol"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(98)70217-0"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(87)90633-3"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.53.2.273"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(89)90079-9"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(89)90284-1"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)80100-3"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(92)90003-6"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.28.10.973"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-116-1-1"},{"key":"e_1_2_1_34_2","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archinte.1994.00420130036007","article-title":"Atrial Fibrillation Investigators: Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized controlled trials","volume":"154","year":"1994","journal-title":"Arch Intern Med"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6088.688"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1253\/jcj.61.673"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(87)80102-9"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410190208"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(97)00854-0"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5273(96)02726-X"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(90)90323-S"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(89)90349-4"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.1990.tb01289.x"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-116-1-6"},{"key":"e_1_2_1_45_2","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1056\/NEJM199011293232201","article-title":"The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators: The effect of low\u2010dose warfarin on the risk of stroke in patients with non\u2010rheumatic atrial fibrillation","volume":"323","year":"1990","journal-title":"N Engl J Med"},{"key":"e_1_2_1_46_2","first-page":"527","article-title":"The Stroke Prevention in Atrial Fibrillation Investigators: Stroke prevention in atrial fibrillation study: Final results","volume":"94","year":"1991","journal-title":"Circulation"},{"key":"e_1_2_1_47_2","first-page":"687","article-title":"The Stroke Prevention in Atrial Fibrillation Investigators: Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: The Stroke Prevention in Atrial Fibrillation Investigators II study","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1052-3057(97)80217-0"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)03487-3"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.16.1273"},{"key":"e_1_2_1_51_2","unstructured":"The Stroke Prevention in Atrial Fibrillation Investigators: Echocardiographic risk stratification in atrial fibrillation: Combined results from BAATAF SPAF I and SPINAF.Arch Intern Med1998."},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1097\/00127893-199809000-00001"}],"container-title":["Echocardiography"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1540-8175.2000.tb01151.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1540-8175.2000.tb01151.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T18:06:15Z","timestamp":1698602775000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1540-8175.2000.tb01151.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,5]]}},"alternative-id":["10.1111\/j.1540-8175.2000.tb01151.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1540-8175.2000.tb01151.x","archive":["Portico"],"relation":{},"ISSN":["0742-2822","1540-8175"],"issn-type":[{"value":"0742-2822","type":"print"},{"value":"1540-8175","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,5]]}}}